Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Ophthalmology Devices Market by Devices (Surgical Devices, Diagnostic and Monitoring Devices) , by Application (Glaucoma, Vitreoretinal Disorders, Cataract, Refractor Disorders) by End User (Hospitals & Eye Clinics, Academic & Research Laboratory, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A01303

Pages: 280

Charts: 59

Tables: 136

Ophthalmology Devices Market Research, 2033

Market Introduction and Definition

The global ophthalmology devices market was valued at $7.1 billion in 2023, and is projected to reach $11.6 billion by 2033, growing at a CAGR of 5.1% from 2024 to 2033. The major factors driving the growth of the ophthalmology devices market are increase in prevalence of eye diseases such as cataracts and age-related macular degeneration, and technological advancements, including innovations in laser surgery and imaging systems. In addition, the rise in geriatric population, surge in awareness of eye health, and development of healthcare infrastructure drive the growth of the market.

Ophthalmology devices play a crucial role in both surgical procedures and diagnostic practices, addressing a range of eye conditions and diseases. Ophthalmic devices are specialized medical instruments used for diagnosing, treating, and managing various eye conditions and diseases. These devices range from diagnostic tools like ophthalmoscopes and slit lamps, which allow ophthalmologists to examine the internal structures of the eye, to therapeutic instruments such as lasers and surgical equipment used in procedures for correcting vision or treating conditions like glaucoma, cataracts, and retinal disorders. In addition, ophthalmic devices include optical coherence tomography (OCT) systems, which provide detailed imaging of the retina, and automated visual field analyzers that assess a patient's peripheral vision.

Key Takeaways 

  • The Ophthalmology Devices market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major Ophthalmology Devices industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and assist stakeholders in making educated decisions to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Devices
    • Surgical Devices
    • Diagnostic and Monitoring Devices
  • By Application
    • Glaucoma
    • Vitreoretinal Disorders
    • Cataract
    • Refractor Disorders
  • By End User
    • Hospitals & Eye Clinics
    • Academic & Research Laboratory
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA

 
Key Market Players

  • Ziemer Ophthalmic Systems Ltd
  • HAAG-STREIT GROUP AG
  • Essilor International S.A
  • TOPCON CORPORATION
  • Alcon Vision LLC
  • Nidek Co. Ltd
  • Johnson & Johnson
  • Canon Medical Systems Corporation
  • Carl Zeiss Meditec AG
  • Bausch & Lomb Incorporated

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: OPHTHALMOLOGY DEVICES MARKET, BY DEVICES

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Devices

    • 4.2. Surgical Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Diagnostic And Monitoring Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: OPHTHALMOLOGY DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Glaucoma

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Vitreoretinal Disorders

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Cataract

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Refractor Disorders

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: OPHTHALMOLOGY DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals And Eye Clinics

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Academic And Research Laboratory

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: OPHTHALMOLOGY DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Devices

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Ophthalmology Devices Market

        • 7.2.6.1. Market Size and Forecast, By Devices
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Ophthalmology Devices Market

        • 7.2.7.1. Market Size and Forecast, By Devices
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Ophthalmology Devices Market

        • 7.2.8.1. Market Size and Forecast, By Devices
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Devices

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Ophthalmology Devices Market

        • 7.3.6.1. Market Size and Forecast, By Devices
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Ophthalmology Devices Market

        • 7.3.7.1. Market Size and Forecast, By Devices
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Ophthalmology Devices Market

        • 7.3.8.1. Market Size and Forecast, By Devices
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Ophthalmology Devices Market

        • 7.3.9.1. Market Size and Forecast, By Devices
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Ophthalmology Devices Market

        • 7.3.10.1. Market Size and Forecast, By Devices
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Ophthalmology Devices Market

        • 7.3.11.1. Market Size and Forecast, By Devices
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Ophthalmology Devices Market

        • 7.3.12.1. Market Size and Forecast, By Devices
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Devices

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Ophthalmology Devices Market

        • 7.4.6.1. Market Size and Forecast, By Devices
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Ophthalmology Devices Market

        • 7.4.7.1. Market Size and Forecast, By Devices
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Ophthalmology Devices Market

        • 7.4.8.1. Market Size and Forecast, By Devices
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Ophthalmology Devices Market

        • 7.4.9.1. Market Size and Forecast, By Devices
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Ophthalmology Devices Market

        • 7.4.10.1. Market Size and Forecast, By Devices
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Ophthalmology Devices Market

        • 7.4.11.1. Market Size and Forecast, By Devices
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Ophthalmology Devices Market

        • 7.4.12.1. Market Size and Forecast, By Devices
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Ophthalmology Devices Market

        • 7.4.13.1. Market Size and Forecast, By Devices
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Ophthalmology Devices Market

        • 7.4.14.1. Market Size and Forecast, By Devices
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Devices

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Ophthalmology Devices Market

        • 7.5.6.1. Market Size and Forecast, By Devices
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Ophthalmology Devices Market

        • 7.5.7.1. Market Size and Forecast, By Devices
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Ophthalmology Devices Market

        • 7.5.8.1. Market Size and Forecast, By Devices
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Ophthalmology Devices Market

        • 7.5.9.1. Market Size and Forecast, By Devices
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Ophthalmology Devices Market

        • 7.5.10.1. Market Size and Forecast, By Devices
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Ophthalmology Devices Market

        • 7.5.11.1. Market Size and Forecast, By Devices
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Johnson And Johnson

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Alcon Vision LLC

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Carl Zeiss Meditec AG

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Bausch And Lomb Incorporated

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Essilor International S.A

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Ziemer Ophthalmic Systems Ltd

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Nidek Co. Ltd

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. TOPCON CORPORATION

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. HAAG-STREIT GROUP AG

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Canon Medical Systems Corporation

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR SURGICAL DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR DIAGNOSTIC AND MONITORING DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR GLAUCOMA, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR VITREORETINAL DISORDERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR CATARACT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR REFRACTOR DISORDERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR HOSPITALS AND EYE CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR ACADEMIC AND RESEARCH LABORATORY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY DEVICES MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY DEVICES MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. NORTH AMERICA OPHTHALMOLOGY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. NORTH AMERICA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 16. NORTH AMERICA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 17. NORTH AMERICA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. U.S. OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 19. U.S. OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 20. U.S. OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. CANADA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 22. CANADA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 23. CANADA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 24. MEXICO OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 25. MEXICO OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 26. MEXICO OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. EUROPE OPHTHALMOLOGY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 28. EUROPE OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 29. EUROPE OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 30. EUROPE OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. FRANCE OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 32. FRANCE OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 33. FRANCE OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 34. GERMANY OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 35. GERMANY OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 36. GERMANY OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 37. ITALY OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 38. ITALY OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 39. ITALY OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. SPAIN OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 41. SPAIN OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. SPAIN OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. UK OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 44. UK OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 45. UK OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. RUSSIA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 47. RUSSIA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 48. RUSSIA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 49. REST OF EUROPE OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 50. REST OF EUROPE OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 51. REST OF EUROPE OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. ASIA-PACIFIC OPHTHALMOLOGY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 53. ASIA-PACIFIC OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 54. ASIA-PACIFIC OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 55. ASIA-PACIFIC OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. CHINA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 57. CHINA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. CHINA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. JAPAN OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 60. JAPAN OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 61. JAPAN OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 62. INDIA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 63. INDIA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 64. INDIA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. SOUTH KOREA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 66. SOUTH KOREA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 67. SOUTH KOREA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 68. AUSTRALIA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 69. AUSTRALIA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 70. AUSTRALIA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. THAILAND OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 72. THAILAND OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. THAILAND OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. MALAYSIA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 75. MALAYSIA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 76. MALAYSIA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 77. INDONESIA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 78. INDONESIA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 79. INDONESIA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 83. LAMEA OPHTHALMOLOGY DEVICES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 84. LAMEA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 85. LAMEA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 86. LAMEA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 87. BRAZIL OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 88. BRAZIL OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 89. BRAZIL OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 90. SOUTH AFRICA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 91. SOUTH AFRICA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 92. SOUTH AFRICA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 93. SAUDI ARABIA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 94. SAUDI ARABIA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 95. SAUDI ARABIA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 96. UAE OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 97. UAE OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 98. UAE OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 99. ARGENTINA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 100. ARGENTINA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 101. ARGENTINA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 102. REST OF LAMEA OPHTHALMOLOGY DEVICES, BY DEVICES, 2025-2033 ($MILLION)
  • TABLE 103. REST OF LAMEA OPHTHALMOLOGY DEVICES, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. REST OF LAMEA OPHTHALMOLOGY DEVICES, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 106. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 107. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 108. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 109. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. ALCON VISION LLC: KEY EXECUTIVES
  • TABLE 111. ALCON VISION LLC: COMPANY SNAPSHOT
  • TABLE 112. ALCON VISION LLC: OPERATING SEGMENTS
  • TABLE 113. ALCON VISION LLC: PRODUCT PORTFOLIO
  • TABLE 114. ALCON VISION LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. CARL ZEISS MEDITEC AG: KEY EXECUTIVES
  • TABLE 116. CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT
  • TABLE 117. CARL ZEISS MEDITEC AG: OPERATING SEGMENTS
  • TABLE 118. CARL ZEISS MEDITEC AG: PRODUCT PORTFOLIO
  • TABLE 119. CARL ZEISS MEDITEC AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. BAUSCH AND LOMB INCORPORATED: KEY EXECUTIVES
  • TABLE 121. BAUSCH AND LOMB INCORPORATED: COMPANY SNAPSHOT
  • TABLE 122. BAUSCH AND LOMB INCORPORATED: OPERATING SEGMENTS
  • TABLE 123. BAUSCH AND LOMB INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 124. BAUSCH AND LOMB INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. ESSILOR INTERNATIONAL S.A: KEY EXECUTIVES
  • TABLE 126. ESSILOR INTERNATIONAL S.A: COMPANY SNAPSHOT
  • TABLE 127. ESSILOR INTERNATIONAL S.A: OPERATING SEGMENTS
  • TABLE 128. ESSILOR INTERNATIONAL S.A: PRODUCT PORTFOLIO
  • TABLE 129. ESSILOR INTERNATIONAL S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. ZIEMER OPHTHALMIC SYSTEMS LTD: KEY EXECUTIVES
  • TABLE 131. ZIEMER OPHTHALMIC SYSTEMS LTD: COMPANY SNAPSHOT
  • TABLE 132. ZIEMER OPHTHALMIC SYSTEMS LTD: OPERATING SEGMENTS
  • TABLE 133. ZIEMER OPHTHALMIC SYSTEMS LTD: PRODUCT PORTFOLIO
  • TABLE 134. ZIEMER OPHTHALMIC SYSTEMS LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. NIDEK CO. LTD: KEY EXECUTIVES
  • TABLE 136. NIDEK CO. LTD: COMPANY SNAPSHOT
  • TABLE 137. NIDEK CO. LTD: OPERATING SEGMENTS
  • TABLE 138. NIDEK CO. LTD: PRODUCT PORTFOLIO
  • TABLE 139. NIDEK CO. LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. TOPCON CORPORATION: KEY EXECUTIVES
  • TABLE 141. TOPCON CORPORATION: COMPANY SNAPSHOT
  • TABLE 142. TOPCON CORPORATION: OPERATING SEGMENTS
  • TABLE 143. TOPCON CORPORATION: PRODUCT PORTFOLIO
  • TABLE 144. TOPCON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. HAAG-STREIT GROUP AG: KEY EXECUTIVES
  • TABLE 146. HAAG-STREIT GROUP AG: COMPANY SNAPSHOT
  • TABLE 147. HAAG-STREIT GROUP AG: OPERATING SEGMENTS
  • TABLE 148. HAAG-STREIT GROUP AG: PRODUCT PORTFOLIO
  • TABLE 149. HAAG-STREIT GROUP AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. CANON MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 151. CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 152. CANON MEDICAL SYSTEMS CORPORATION: OPERATING SEGMENTS
  • TABLE 153. CANON MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 154. CANON MEDICAL SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL OPHTHALMOLOGY DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL OPHTHALMOLOGY DEVICES MARKET
  • FIGURE 3. SEGMENTATION OPHTHALMOLOGY DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN OPHTHALMOLOGY DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALOPHTHALMOLOGY DEVICES MARKET
  • FIGURE 11. OPHTHALMOLOGY DEVICES MARKET SEGMENTATION, BY BY DEVICES
  • FIGURE 12. OPHTHALMOLOGY DEVICES MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. OPHTHALMOLOGY DEVICES MARKET FOR DIAGNOSTIC AND MONITORING DEVICES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. OPHTHALMOLOGY DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 15. OPHTHALMOLOGY DEVICES MARKET FOR GLAUCOMA, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. OPHTHALMOLOGY DEVICES MARKET FOR VITREORETINAL DISORDERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. OPHTHALMOLOGY DEVICES MARKET FOR CATARACT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. OPHTHALMOLOGY DEVICES MARKET FOR REFRACTOR DISORDERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. OPHTHALMOLOGY DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. OPHTHALMOLOGY DEVICES MARKET FOR HOSPITALS AND EYE CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. OPHTHALMOLOGY DEVICES MARKET FOR ACADEMIC AND RESEARCH LABORATORY, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. OPHTHALMOLOGY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: OPHTHALMOLOGY DEVICES MARKET
  • FIGURE 29. TOP PLAYER POSITIONING, 2024
  • FIGURE 30. JOHNSON AND JOHNSON: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 31. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 32. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 33. ALCON VISION LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 34. ALCON VISION LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 35. ALCON VISION LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 36. CARL ZEISS MEDITEC AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 37. CARL ZEISS MEDITEC AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 38. CARL ZEISS MEDITEC AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 39. BAUSCH AND LOMB INCORPORATED: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 40. BAUSCH AND LOMB INCORPORATED: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 41. BAUSCH AND LOMB INCORPORATED: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 42. ESSILOR INTERNATIONAL S.A: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 43. ESSILOR INTERNATIONAL S.A: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 44. ESSILOR INTERNATIONAL S.A: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 45. ZIEMER OPHTHALMIC SYSTEMS LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 46. ZIEMER OPHTHALMIC SYSTEMS LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 47. ZIEMER OPHTHALMIC SYSTEMS LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 48. NIDEK CO. LTD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 49. NIDEK CO. LTD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 50. NIDEK CO. LTD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 51. TOPCON CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 52. TOPCON CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 53. TOPCON CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 54. HAAG-STREIT GROUP AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 55. HAAG-STREIT GROUP AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 56. HAAG-STREIT GROUP AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 57. CANON MEDICAL SYSTEMS CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 58. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 59. CANON MEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Ophthalmology Devices Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved